US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 133.460
  • +0.120+0.09%
Close Aug 16 16:00 ET
  • 131.036
  • -2.424-1.82%
Post 20:01 ET
12.73BMarket Cap177.95P/E (TTM)

Sarepta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sarepta Therapeutics Q2 2024 Earnings Date

Currency：USDAug 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
387.33M
362.93M
-24.40M
Miss Est.
+48.27%
+38.93%
-6.30%
EPS
-0.01
0.07
+0.08
Beat Est.
+95.33%
+125.93%
+655.56%
Analyst Rating
Strong Buy

Aug 17, 2024

Sarepta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 562.165M--
--2024/Q3-- / 403.215M--
Aug 7, 20242024/Q2362.931M / 387.326M--
May 1, 20242024/Q1413.464M / 375.429M--
Feb 28, 20242023/Q4396.781M / 386.164M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 562.165M--
--2024/Q3-- / 403.215M--
Aug 7, 20242024/Q2362.931M / 387.326M--
May 1, 20242024/Q1413.464M / 375.429M--
Feb 28, 20242023/Q4396.781M / 386.164M--

Unlock Free Earnings Estimates

Sarepta Therapeutics Earnings Reports

  • Sarepta Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:07 ET

  • Sarepta Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 1 16:07 ET

  • Sarepta Therapeutics | 10-K: FY2023 Annual Report

    Feb 28 16:11 ET

  • Sarepta Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 17, 2024

    Strong Buy

    • Buy

      90.00%

    • Hold

      10.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg